Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOLVAPTAN for Nephropathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TOLVAPTAN was used for Nephropathy.

Most Reported Side Effects for TOLVAPTAN

Side Effect Reports % Deaths Hosp.
Death 800 8.9% 799 82
Thirst 624 6.9% 37 120
Off label use 560 6.2% 63 69
Renal impairment 534 5.9% 48 103
Underdose 448 5.0% 117 153
Product use in unapproved indication 446 5.0% 159 172
Wrong technique in product usage process 426 4.7% 161 178
Polyuria 390 4.3% 12 90
Product dose omission issue 379 4.2% 11 70
Inappropriate schedule of product administration 376 4.2% 111 157
Blood creatinine increased 337 3.7% 33 100
Dehydration 315 3.5% 49 157
Fatigue 287 3.2% 11 59
Pollakiuria 280 3.1% 4 57
Blood sodium decreased 278 3.1% 32 199

Other Indications for TOLVAPTAN

Congenital cystic kidney disease (3,479) Product used for unknown indication (1,444) Hyponatraemia (1,029) Cardiac failure (601) Inappropriate antidiuretic hormone secretion (372) Blood osmolarity decreased (339) Fluid retention (300) Cardiac failure congestive (178) Blood sodium decreased (167) Oedema due to cardiac disease (166)

Other Drugs Used for Nephropathy

PARICALCITOL (2,534) PREDNISONE (138) CYCLOSPORINE (130) LEFLUNOMIDE (119) ZEMPLAR (81) RAMIPRIL (47) RITUXIMAB (41) METHYLPREDNISOLONE (34) MYCOPHENOLATE MOFETIL (32) CYCLOPHOSPHAMIDE (30)

Related Pages

TOLVAPTAN Full Profile All Nephropathy Drugs TOLVAPTAN Demographics TOLVAPTAN Timeline